Allspring Global Investments
URGN icon

Allspring Global Investments’s UroGen Pharma URGN Stock Holding History

Allspring Global Investments’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,298
Closed -$88.9K – 2594
2024
Q2 		$88.9K Buy
5,298
+335
+7% +$4.76K ﹤0.01% 1872
2024
Q1 		$74.4K Buy
4,963
+8
+0.2% +$131 ﹤0.01% 1893
2023
Q4 		$74.3K Buy
4,955
+1,191
+32% +$15.5K ﹤0.01% 1839
2023
Q3 		$52.7K Buy
+3,764
New +$60.4K ﹤0.01% 2247
2022
Q2 		– Sell
-47,728
Closed -$415K – 2943
2022
Q1 		$415K Buy
47,728
+6,894
+17% +$53.8K ﹤0.01% 2300
2021
Q4 		$388K Buy
+40,834
New +$576K ﹤0.01% 2403

Other funds holding URGN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Allspring Global Investments's URGN Position: Q3 2024 in Review

Allspring Global Investments sold out of UroGen Pharma (URGN) in Q3 2024, closing a stake of 5,298 shares — an estimated $88.9K sold.

Allspring Global Investments first reported a position in URGN in Q4 2021 and held it in 6 quarters. The position peaked at $415K in Q1 2022. 128 funds tracked by Wall St. Rank hold URGN as of Q3 2024.

  • Allspring Global Investments reported no remaining UroGen Pharma position as of Q3 2024 after selling out during the quarter.
  • Allspring Global Investments sold 5,298 UroGen Pharma shares in Q3 2024, an estimated $88.9K.
  • Allspring Global Investments first reported a position in UroGen Pharma in Q4 2021 and held it in 6 quarters.
  • Allspring Global Investments's UroGen Pharma position peaked at $415K in Q1 2022.
  • 128 funds tracked by Wall St. Rank held UroGen Pharma as of Q3 2024.

Based on Allspring Global Investments's 13F filing for Q3 2024, filed 18 Oct 2024.